OROFAR

This brand name is authorized in Lithuania, Poland, Romania.

Active ingredients

The drug OROFAR contains a combination of these active pharmaceutical ingredients (APIs):

1	Benzoxonium UNII 12IMO9R11X - BENZOXONIUM CHLORIDE
	Benzoxonium is an antiseptic/disinfectant.
	Read more about Benzoxonium
2	Lidocaine UNII 98PI200987 - LIDOCAINE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R02AA20	Various	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1020680, 1026326, 1029924
PL	Rejestru Produktów Leczniczych	100107597, 100113221
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67096001, W67097001